44, 77 Methymalonic acid, a metabolite of PPA, results in abnormal mitochondrial morphology, 78 tissue specific ETC dysfunction, 79 inhibition of the complex I and II function when interacting with complex III in the brain 80 and reductions in reduced glutathione, 78 similar to the patient cohort presented and the PPA animal model
These peptides are studied for their potential role in: focus memory stress regulation 5
How worried you should be depends on how much aspartame you consume
#Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare @DLBHATTMD @CMichaelGibson @TheLancetEndo @TheLancet @iamritu @hvanspall @DrMarthaGulati thelancet.com/journals/lance Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial In individuals with type 2 diabetes inadequately controlled with metformin, orforglipron 12 mg and 36 mg was non-inferior and superior to semaglutide 7 mg and 14 mg with respect to the mean change in HbA1c from baseline to 52 weeks
Additionally, conflicting findings suggest that prolonged metformin treatment may exacerbate AD pathology in genetically susceptible models, increasing -amyloid accumulation, tau phosphorylation, and synaptic dysfunction 92
Alcohol makes these worse, especially when drinking on an empty stomach or during dose increases
